Pluri Gets Nasdaq Delisting Warning — Must Reclaim $35M Market Value by January 2027
PLUR is trading near its 52-week low of $1.59 (2.5% above the low) on elevated volume (2.5× avg).
Summary
Pluri received a Nasdaq delisting notice after its market value fell below the $35 million minimum. The company has until January 4, 2027 to regain compliance, but with a market cap of just $17.6 million and shares near 52-week lows, the path back is uncertain.
Key Events · Legal and Risk Events · PLUR
-
Nasdaq Delisting Notice Received
On July 7, 2026, Pluri was notified it fails the $35 million market value of listed securities (MVLS) requirement, with a current market cap of approximately $17.6 million.
-
180-Day Compliance Window
The company has until January 4, 2027 to achieve a closing MVLS of $35 million or more for at least 10 consecutive business days.
-
Alternative Standards Also Unmet
Pluri does not meet the alternative listing standards of $2.5 million in stockholders' equity or $500,000 in net income from continuing operations.
-
Delisting Risk Amid Liquidity Crisis
The notice compounds existing distress: less than three months of cash runway, a $27.4 million EIB loan due, and recent emergency funding from the chairman.
Analysis · PLUR · Life Sciences
Nasdaq has formally warned Pluri that its market value has slipped below the $35 million minimum required for continued listing. The company now has 180 days to push its market cap back above that threshold for 10 consecutive trading days. With a current market cap around $17.6 million and shares trading near all-time lows, the path to compliance is steep — likely requiring a reverse stock split or a dramatic share-price recovery. This unfolds against a backdrop of acute cash shortages, a looming $27.4 million loan repayment, and recent emergency funding from its chairman. A delisting would severely impair liquidity and access to capital, compounding the company's survival challenges.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.7% of the 583 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $1.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.6M. The 52-week trading range was $1.59 to $5.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.